Comparison of an activated partial thromboplastin time with a russell viper venom time test in screening for factor V(Leiden) (FVR506Q)

American Journal of Clinical Pathology

Volumn 108, Issue 1, 1997, Pages 74-77

  Sweeney, Joseph D ^a   Blair, Abbe J ^a   King, Thomas C ^a  

^a MIRIAM HOSPITAL   (United States)

Author keywords

Factor V(Leiden); Partial thromboplastin time PTT ; Polymerase chain reaction; Russell viper venom time RVVT

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; VIPER VENOM;

ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOPHILIA;

EID: 0030974089     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.1.74     Document Type: Article

References (25)

1. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
2. Koster T, Rosendaal FR, de Ronde H, Brict E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503-1506.
3. Zoller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994;343:1536-1538.
4. Tuddenham EGD. Thrombophilia: the new factor is old factor V. Lancet. 1994;343:1515-1516.
5. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993;90:1004-1008.
6. 506 of factor V. Lancet. 1994;343:1535-1536.
7. Svensson FJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-522.
8. Leiden mutation. Lancet. 1994;344:1453-1457.
9. Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.
10. Leiden. Lancet. 1995;346:1133-1134.
11. Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1-13.
12. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-3544.
13. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilia patients. Blood. 1993;82:1989-1993.
14. Leiden. Am J Clin Pathol. 1996;106:107-111.
15. Vasse M, Leduc O, Borg JY, Chretien MH, Monconduit M. Resistance to activated protein C: evaluation of three functional assays. Thromb Res. 1994;76:47-59.
16. Kraus M, Zander N, Fickenscher K. Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C. Thromb Res. 1995;80:255-264.
17. McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens. Thromb Haemost. 1983;50:757. Letter.
18. Cox JC, Endes-Brooks J, Bauer PJ, Marks WJ, Montegomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69:1691-1695.
19. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol 1964;10:238-245.
20. Olsen JD. Activated protein C resistance: the challenge of diagnosis. CAP Today. 1996;10:85-87.
21. de Ronde H, Bertina RM. Laboratory diagnosis of APC resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost. 1994;72:880-886.
22. van der Bom JG, Bots ML, Haverkate F, et al. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med. 1996;125:265-269.
23. Cortellaro M, Boschetti C, Cofrancesco E, et al. The PLAT study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis. 1991;90:109-118.
24. Hager K, Setzer J, Voge T, Voit J, Platt D. Blood coagulation factors in the elderly. Archives Gerontology Geriatrics. 1989;9:277-282.
25. Meade TW, Chakrabarti R, Haines AP, et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980;1:1050-1054.